Related Experiment Videos
Should physicians participate in affirming the best approach to atrial fibrillation management?
The American Journal of Cardiology
|November 15, 1996
Insights
For atrial fibrillation patients, anticoagulation and ventricular response control are standard. However, the long-term benefits of restoring normal heart rhythm require further investigation in clinical trials.
Area of Science:
- Cardiology
- Electrophysiology
- Clinical Trials
Background:
- Atrial fibrillation necessitates anticoagulation and ventricular rate control for all patients.
- The long-term prognostic value of achieving sinus rhythm in atrial fibrillation remains uncertain.
- Current physician practices indicate a strong preference (90%) for pursuing sinus rhythm conversion.
Discussion:
- Physician preference for sinus rhythm conversion in atrial fibrillation is high.
- Understanding the long-term outcomes associated with sinus rhythm restoration is crucial.
- Physician practices may influence patient management strategies and trial participation.
Key Insights:
- While standard treatments exist for atrial fibrillation, the benefit of sinus rhythm conversion is not well-defined.
- A significant majority of physicians favor attempting conversion to sinus rhythm.
- Participation in the National Institute of Health atrial fibrillation trial is encouraged.
Outlook:
- Further research is needed to clarify the long-term impact of sinus rhythm conversion on patient outcomes.
- Investigating physician practices can inform clinical guideline development.
- The National Institute of Health trial aims to provide critical data on atrial fibrillation management.
Abstract:
While all patients with atrial fibrillation should receive anticoagulation and control of ventricular response, it is not clear whether conversion to sinus rhythm is associated with a good long-term outcome. Data are presented detailing current physician practices regarding conversion to sinus rhythm (preferred by 90%) and why participation in the new National Institute of Health trial of atrial fibrillation is desirable.